SUBJECTS : Cancer Biology | Molecular Carcinogenesis | | Stem Cells | Developmental Biology | Oncolog
LATEST MANUSCRIPTS IN Cancer Treatment and Research Communications
- Dordi Lea, Claudia Zaharia, Kjetil Søreide. Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, CPS and IC) scores. Cancer treatment and research communications. 2023, 38: 100788
Cited : 3Read More - Sanchay Jain, Vandana Dhingra, Bhavna Girdhani. Scope of PET imaging in the evaluation of cardiac tumors. Cancer treatment and research communications. 2023, 37: 100754Cited : 3Read More
- Satoshi Endo, Takayuki Honda, Kazuaki Sato, Natsushi Kubota, Tatsuhiko Kamoshida, Akifumi Mochizuki, Mayumi Fujii, Junichi Ochi, Yasunari Miyazaki, Yoshikazu Tsukada. Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world study. Cancer treatment and research communications. 2023, 37: 100755Cited : 2Read More
- Nikit Venishetty, Jessica Calderon-Mora, Navkiran K Shokar, Pracheta Matharasi, Luis Garza, Celina Beltran, Jennifer Molokwu. Implementing a mailed stool sample screening program in clinics providing care for an underserved Hispanic population. Cancer treatment and research communications. 2023, 37: 100756Cited : 0Read More
- Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Chrysanthi Sardeli. Sotorasib after immune checkpoint inhibitor administration induces hepatotoxicity. True, false or just another adverse effect of NSCLC treatment. Cancer treatment and research communications. 2023, 37: 100757Cited : 0Read More
- Zhaoqing Yu, Li Qin, Guifang Yu. The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patients. Cancer treatment and research communications. 2023, 37: 100758Cited : 0Read More
- Rossella Libé, Olivier Huillard. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer treatment and research communications. 2023, 37: 100759Cited : 3Read More
- Deepthi Valiyaveettil, Deepa Joseph, Monica Malik. Cardiotoxicity in breast cancer treatment: Causes and mitigation. Cancer treatment and research communications. 2023, 37: 100760Cited : 2Read More
- Lisa M Hess, Patrick Peterson, Tomoko Sugihara, Naleen Raj Bhandari, Peter M Krein, Anthony Sireci. Initial versus early switch to targeted therapy during first-line treatment among patients with biomarker-positive advanced or metastatic non-small cell lung cancer in the United States. Cancer treatment and research communications. 2023, 37: 100761Cited : 1Read More
- Paul Zarogoulidis, Dimitris Matthaios, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Chrysanthi Sardeli. Immunotherapy for the elderly. Maybe the best option for lung cancer? Cancer treatment and research communications. 2023, 37: 100762Cited : 0Read More
- Lauren Holladay, Jennie Luu, Vyshnavy Balendra, Kevin Kmetz. Current and potential treatment of colorectal cancer metastasis to bone. Cancer treatment and research communications. 2023, 37: 100763Cited : 2Read More
- Kamal Basri Siregar, Muhammad Al Anas. Unveiling bone metastasis: Exploring histological subtypes of breast cancer in Indonesia's tertiary referral hospital. Cancer treatment and research communications. 2023, 37: 100764Cited : 0Read More
- Ugonma Winnie Dozie, Onyinyechi Vivian Ezeala, Chinaecherem Innocent David, Kelechukwu Celestin Nosike Dozie, Uchechukwu Madukaku Chukwuocha, Chimezie Christian Iwuala, Nkechi Joy Osuoji, Chisomuaga Chidinma Okoro, Ogechi Rita Chukwu, Stanley Chinedu Eneh, Ikechukwu Nosike Simplicius Dozie. Factors associated with health seeking delay in the screening of cervical cancer among women in Imo state, south Eastern Nigeria. Cancer treatment and research communications. 2023, 37: 100765Cited : 1Read More
- Setyo Teguh Waluyo, Brahmana Askandar Tjokroprawiro, Anny Setijo Rahaju. Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristics. Cancer treatment and research communications. 2023, 37: 100766Cited : 0Read More
- Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, Wiam Belkaid, Danh Tran-Thanh, Julie Malo, Marion Tonneau, Omar El Ouarzadi, Marie Florescu, Mustapha Tehfe, Normand Blais. The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy. Cancer treatment and research communications. 2023, 37: 100767Cited : 2Read More
